Risk of cardiovascular disease in post COVID-19 patients
Authors:
Company:
1 Davydovskiy City Clinical Hospital, Moscow, Russian Federation
2 Cardiology Chair of A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Moscow, Russian Federation MSUMD
For correspondence: Sign in or register.
Type: Editorial article
DOI:
For citation: Vasilieva E.Yu., Elizarova A.K. Risk of cardiovascular disease in post COVID-19 patients. Creative Cardiology. 2022; 16 (3): 273–7 (in Russ.). DOI: 10.24022/1997-3187-2022-16-3-273-277
Received / Accepted: 31.08.2022 / 02.09.2022
Keywords: COVID-19 post-COVID-19 syndrome, cardiovascular disease, myocardial injury, endothelial dysfunction
Abstract
As the COVID-19 pandemic began, various non-specific symptoms were detected among recovered patients, such as general weakness, fatigue and insomnia. Later different studies described an increase in the incidence of cardiovascular complications (myocardial infarction, stroke, arrhythmia, myocarditis, pulmonary embolism, heart failure, hypertensive crisis) after a COVID-19 infection, while the exact mechanisms remain unclear. This article depicts the most significant data currently available on the incidence of cardiovascular complications after a COVID-19 infection and also describes some of the possible pathogenetic mechanisms.References
- Daugherty S.E., Guo Y., Heath K., Dasmariñas M.C., Jubilo K.G., Samranvedhya J. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. B. M. J. 2021; 373: n1098. DOI: 10.1136/bmj.n1098
- Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022; 28 (3): 583–90. DOI: 10.1038/s41591-022-01689-3
- Raisi-Estabragh Z., Cooper J., Salih A., Raman B., Lee A.M., Neubauer S. et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022; heartjnl-2022-321492. DOI: 10.1136/heartjnl-2022-321492
- Wang W., Wang C.Y., Wang S.I., Wei J.C. Longterm cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022; 53: 101619. DOI: 10.1016/j.eclinm.2022.101619
- Puntmann V.O., Martin S., Shchendrygina A., Hoffmann J., Ka M.M., Giokoglu E. et al. Longterm cardiac pathology in individuals with mild initial COVID-19 illness. Nat. Med. 2022; 28 (10): 2117–23. DOI: 10.1038/s41591-022-02000-0
- Øvrebotten T., Myhre P., Grimsmo J., Mecinaj A., Trebinjac D., Nossen M.B. et al. Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19. Clin. Cardiol. 2022; 45 (10): 1044–52. DOI: 10.1002/clc.23891
- Luchian M.L., Motoc A., Lochy S., Magne J., Belsack D., De Mey J. et al. Subclinical myocardial dysfunction in patients with persistent dyspnea one year after COVID-19. Diagnostics (Basel). 2021; 12 (1): 57. DOI: 10.3390/diagnostics12010057
- Santoro L., Falsetti L., Zaccone V., Nesci A., Tosato M., Giupponi B. et al. On behalf of gemelli against covid-post-acute care study group. Impaired endothelial function in convalescent phase of COVID-19: a 3 month follow up observational prospective study. J. Clin. Med. 2022; 11 (7): 1774. DOI: 10.3390/jcm11071774
- Prasad M., Leon M., Lerman L.O., Lerman A. Viral endothelial dysfunction: a unifying mechanism for COVID-19. Mayo Clin. Proc. 2021; 96 (12): 3099–108. DOI: 10.1016/j.mayocp.2021.06.027
About Authors
- Elena Yu. Vasilieva, Dr. Med. Sci., Professor, Head of Laboratory of MSUMD of A.I. Yevdokimov, President of Davydovskiy CC; ORCID
- Antonina K. Elizarova, Postgraduate of Cardiology Chair of MSUMD of A.I. Yevdokimov, Cardiologist of Department of Cardiology for Patients with Acute Myocardial Infarction of Davydovskiy CCH; ORCID
